Intravitreal Anakinra Inhibits Choroidal Neovascular Membrane Growth in a Rat Model

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Ocular immunology and inflammation

• Publication date

  2009-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/09273940802710705PMID 19585363
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Constitutive Repression of Interleukin-1&agr; in Endothelial Cells

  2008cited by this paper
• Intravitreal infliximab and choroidal neovascularization in an animal model.

  2007cited by this paper
• Effect of Interleukin-1 Blockers, CK112, and CK116 on Rat Experimental Choroidal Neovascularization In Vivo and Endothelial Cell Cultures In Vitro

  2006cited by this paper
• Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1

  2006cited by this paper
• TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts.

  2005cited by this paper
• Induction of vascular endothelial growth factor and matrix metalloproteinase-3 (stromelysin) by interleukin-1 in human articular chondrocytes and synoviocytes

  2005cited by this paper
• Suppression and regression of choroidal neovascularization by polyamine analogues.

  2005cited by this paper
• The many worlds of reducing interleukin-1.

  2005cited by this paper
• Interleukin-1 Receptor Antagonist Inhibits the Expression of Vascular Endothelial Growth Factor in Colorectal Carcinoma

  2005cited by this paper
• Mice Transgenic for IL-1 Receptor Antagonist Protein Are Resistant to Herpetic Stromal Keratitis: Possible Role for IL-1 in Herpetic Stromal Keratitis Pathogenesis1

  2004cited by this paper
• VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2004cited by this paper
• Counteracting corneal immunoinflammatory lesion with interleukin‐1 receptor antagonist protein

  2004cited by this paper
• Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study.

  2004cited by this paper
• Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina.

  2004cited by this paper
• A continuous delivery system of IL‐1 receptor antagonist reduces angiogenesis and inhibits tumor development

  2004cited by this paper
• Prevalence of age-related macular degeneration in the United States.

  2004cited by this paper
• Pegaptanib for neovascular age-related macular degeneration.

  2004cited by this paper
• Prevalence of open-angle glaucoma among adults in the United States.

  2004cited by this paper
• Upregulation of vascular endothelial growth factor (VEGF) in the retinas of transgenic mice overexpressing interleukin-1beta (IL-1beta) in the lens and mice undergoing retinal degeneration.

  2003cited by this paper
• Cytokine traps: multi-component, high-affinity blockers of cytokine action

  2003cited by this paper
• The PLC-PKC cascade is required for IL-1beta-dependent Erk and Akt activation: their role in proliferation.

  2003cited by this paper
• IL-1 is required for tumor invasiveness and angiogenesis

  2003cited by this paper
• Investigation of laser-induced choroidal neovascularization in the rat.

  2003cited by this paper
• Expression and Functional Role for the Serum and Glucocorticoid Regulated Kinase, and the Epithelial Sodium Channel in Human Ocular Ciliary Epithelium

  2002cited by this paper
• The inflammatory milieu associated with conjunctivalized cornea and its alteration with IL-1 RA gene therapy.

  2002cited by this paper
• Quantitative assessment of the integrity of the blood-retinal barrier in mice.

  2002cited by this paper
• Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

  2002cited by this paper
• Optimal methods for preparation and immunostaining of iris, ciliary body, and choroidal wholemounts.

  2000cited by this paper
• Quantitative image analysis of laser-induced choroidal neovascularization in rat.

  2000cited by this paper
• The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.

  1999cited by this paper
• Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta.

  1997cited by this paper
• Blood‐retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: Comparison with vascular endothelial growth factor, tumor necrosis factor α, and interleukin‐1β‐mediated breakdown

  1997cited by this paper
• Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor.

  1996cited by this paper
• Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide.

  1996cited by this paper
• Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

  1995cited by this paper
• Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

  1995cited by this paper
• Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis

  1995cited by this paper
• Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• Pathogenesis of laser-induced choroidal subretinal neovascularization.

  1990cited by this paper
• Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate.

  1985cited by this paper
• A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.

  1985cited by this paper
• Subretinal neovascularization. Natural history of an experimental model.

  1982cited by this paper

• A Polytherapy Intervention in an Experimental Traumatic Optic Neuropathy Mouse Model.

  2025cites this paper
• AAV-mediated inducible co-expression of IL-10 and IL-1RN for ocular inflammatory diseases

  2025cites this paper
• The Impact of ARMS2 (rs10490924), VEGFA (rs3024997), TNFRSF1B (rs1061622), TNFRSF1A (rs4149576), and IL1B1 (rs1143623) Polymorphisms and Serum Levels on Age-Related Macular Degeneration Development and Therapeutic Responses

  2024cites this paper
• SPI1-mediated macrophage polarization aggravates age-related macular degeneration

  2024cites this paper
• Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases

  2024cites this paper
• Targeting inflammasomes and pyroptosis in retinal diseases-molecular mechanisms and future perspectives.

  2024cites this paper
• Bispecific VEGF-A and Angiopoietin-2 Antagonist RO-101 Preclinical Efficacy in Model of Neovascular Eye Disease

  2024cites this paper
• Microglia in retinal diseases: From pathogenesis towards therapeutic strategies.

  2024cites this paper
• Locked and loaded: targeting extracellular vesicles to preserve sight

  2023cites this paper
• Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action

  2022cites this paper
• Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum – a systematic review

  2022cites this paper
• Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)

  2022cites this paper
• Targeting Microglia to Treat Degenerative Eye Diseases

  2022cites this paper
• Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy

  2021cites this paper
• Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis

  2021cites this paper
• The Role of Inflammation in Age-Related Macular Degeneration

  2020cites this paper
• Angiographic Review of Choroidal Involution in Eyes with Retinopathy of Prematurity Treated with Bevacizumab

  2020cites this paper
• Microglia Contribution to the Regulation of the Retinal and Choroidal Vasculature in Age-Related Macular Degeneration

  2020cites this paper
• The role of inflammation in diabetic eye disease

  2019cites this paper
• Microglia in the Retina: Roles in Development, Maturity, and Disease.

  2018cites this paper
• Systemic immunosuppression and risk of age-related macular degeneration

  2018cites this paper
• Anti-angiogenic effects of biotechnological therapies in rheumatic diseases

  2017cites this paper
• The effect of anakinra on retinal function in isolated perfused vertebrate retina

  2017cites this paper
• The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases

  2017cites this paper
• On phagocytes and macular degeneration

  2017influential citation
• Long‐term efficacy and safety of the interleukin‐1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma

  2017cites this paper
• Choroidal Involution Is Associated with a Progressive Degeneration of the Outer Retinal Function in a Model of Retinopathy of Prematurity: Early Role for IL-1β.

  2016cites this paper
• Fracción activa del factor derivado del epitelio pigmentario (PEDF) en el tratamiento de la neovascularización coroidea en modelo animal de degeneración macular asociada a la edad

  2016cites this paper
• NLRP3 Inflammasome and Pathobiology in AMD

  2015cites this paper
• An Experimental Study on Choroidal Neovascularization Induced by Krypton Laser in Rat Model

  2014cites this paper
• Immuno-modulatory Effect of IFN-gamma in AMD and its Role as a Possible Target for Therapy

  2013cites this paper
• Microglia and Interleukin-1&bgr; in Ischemic Retinopathy Elicit Microvascular Degeneration Through Neuronal Semaphorin-3A

  2013cites this paper
• Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar.

  2013cites this paper
• Animal models of age related macular degeneration.

  2012cites this paper
• Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

  2012cites this paper
• Pathogenic Roles of Sterile Inflammation in Etiology of Age-Related Macular Degeneration

  2012cites this paper
• Type I Interferons and the Development of Impaired Vascular Function and Repair in Human and Murine Lupus

  2011cites this paper
• Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

  2011cites this paper
• Interleukin-1β inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration.

  2011cites this paper
• Why not treat human cancer with interleukin-1 blockade?

  2010cites this paper
• Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF.

  2010cites this paper
• Blockade of the sonic hedgehog signalling pathway inhibits choroidal neovascularization in a laser-induced rat model

  2010cites this paper
• Blockade of the sonic hedgehog signalling pathway inhibits choroidal neovascularization in a laser-induced rat model

  2010cites this paper